EKF Diagnostics Holdings PLC Trading update (2483K)
July 06 2017 - 2:00AM
UK Regulatory
TIDMEKF
RNS Number : 2483K
EKF Diagnostics Holdings PLC
06 July 2017
EKF Diagnostics Holdings plc
("EKF", the "Company")
Trading update
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed
point-of-care business, provides an update on current trading.
The Company is pleased to announce that the trading in the
second quarter of the year has continued the favourable trends
experienced in the first quarter.
In particular, June sales were notably strong. This is entirely
due to organic growth with no major tenders won during the
period.
As a consequence, the Company expects adjusted EBITDA for 2017
will be comfortably ahead of current market forecasts.
Finally, despite the cancellation of the stock option scheme at
a cost of GBP1.5m cash generation has been very strong with net
cash at 30 June of approximately GBP4.0m.
This announcement contains information which, prior to its
disclosure, was considered inside information for the purposes of
Article 7 of Regulation (EU) No 596/2014 (MAR).
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Tel: 029 2071 0570
Chairman
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Alex Price / Alex Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584
391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLLFLRDTIEIID
(END) Dow Jones Newswires
July 06, 2017 02:00 ET (06:00 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Sep 2023 to Sep 2024